Epoch Investment Partners’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-238,699
Closed -$7.53M 411
2023
Q4
$7.53M Sell
238,699
-27,515
-10% -$747K 0.03% 276
2023
Q3
$7.47M Sell
266,214
-66,404
-20% -$2.28M 0.05% 273
2023
Q2
$12.3M Buy
332,618
+1,654
+0.5% +$50.5K 0.07% 253
2023
Q1
$9.91M Buy
+330,964
New +$10.9M 0.06% 275
2022
Q1
Sell
-14,470
Closed -$485K 444
2021
Q4
$485K Buy
14,470
+3,820
+36% +$119K ﹤0.01% 325
2021
Q3
$309K Buy
10,650
+1,179
+12% +$38.2K ﹤0.01% 339
2021
Q2
$329K Buy
+9,471
New +$314K ﹤0.01% 327

Other funds holding CC

Epoch Investment Partners's CC Position: Q1 2024 in Review

Epoch Investment Partners sold out of Chemours (CC) in Q1 2024, closing a stake of 238,699 shares — an estimated $7.53M sold.

Epoch Investment Partners first reported a position in CC in Q2 2021 and held it in 7 quarters. The position peaked at $12.3M in Q2 2023. 443 funds tracked by Wall St. Rank hold CC as of Q1 2024.

  • Epoch Investment Partners reported no remaining Chemours position as of Q1 2024 after selling out during the quarter.
  • Epoch Investment Partners sold 238,699 Chemours shares in Q1 2024, an estimated $7.53M.
  • Epoch Investment Partners first reported a position in Chemours in Q2 2021 and held it in 7 quarters.
  • Epoch Investment Partners's Chemours position peaked at $12.3M in Q2 2023.
  • 443 funds tracked by Wall St. Rank held Chemours as of Q1 2024.

Based on Epoch Investment Partners's 13F filing for Q1 2024, filed 14 May 2024.